CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing glycosylated nanoparticles to enhance their stability and targeting efficacy for biomedical applications. By improving their interaction with biological systems, the research aims to address challenges in drug delivery, diagnostics, and vaccine development.
Nanomedicine is currently the most studied and promising topics in the field of biomedical technology, which is focused on developing nanoparticles.
The reason for this is that these materials present unique properties such as size, high ratio area/ volume, chemical reactivity, that offer potential solutions for many of the current challenges in diagnosis, therapy and vaccines on several diseases.
However, the safe use of NPs in clinical applications is not established yet.
At present, the NPs h…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
